| Document |
Document Title |
|
WO/2016/135542A1 |
A process for the production of dipentyl ether from levulinic acid resulting from biomass including at least one polysaccharide comprising the following steps: (a) reacting said levulinic acid in the presence of hydrogen and at least one...
|
|
WO/2016/135616A1 |
The present invention provides an improved process for the preparation of 4-((2-isopropoxy ethoxy) methyl) phenol compound (I), used as an intermediate in many organic synthesis; particularly a key intermediate for the synthesis of l-[4[...
|
|
WO/2016/129602A1 |
The present invention provides a method for easily and efficiently manufacturing a fluorine-containing diene compound from a fluorine-containing olefin that can be easily obtained industrially, the method enabling the fluorine atoms to b...
|
|
WO/2016/129148A1 |
Provided is a lubricant composition which has high moisture resistance, while having physical properties such as low viscosity, low evaporativity, low-temperature fluidity and high viscosity index. This lubricant composition contains an ...
|
|
WO/2016/127492A1 |
A tetra-phenolic compound/tetra-functionality epoxy resin, a preparation method and application thereof. The tetra-phenolic compound is obtained by reacting p-hydroxybenzaldehyde with an alkyl bromide, and then reacting the product there...
|
|
WO/2016/129679A1 |
A compound represented by formula (1). (In formula (1): R1 represents a C1-30 2n-valent group, and R2 through R5 each independently represent a C1-10 alkyl group, a C6-10 aryl group, a C2-10 alkenyl group, a C1-30 alkoxy group, a thiol g...
|
|
WO/2016/123707A1 |
The present application relates to a novel process for the preparation of difluoromethyl ether-based derivatives from, for example, aliphatic and aromatic hydroxyl precursors, compositions comprising these compounds and their use, in par...
|
|
WO/2016/125185A2 |
The present invention provides the process for the preparation of 4-substituted-1- (trifluoromethoxy) benzene compounds..
|
|
WO/2016/119757A1 |
The present invention relates to a method for preparing a 2-[1-cycloalkylethyl] phenol derivative, i.e. a method for preparing a compound as shown in formula (I) and an isomer thereof, and an intermediate, and the method has the advantag...
|
|
WO/2016/119758A1 |
The present invention relates to a method for preparing a chiral 2-[1-cycloalkylethyl] phenol derivative, the preparation method comprises the catalytic hydrogenation of a compound of general formula (II) to prepare and obtain a compound...
|
|
WO/2016/121691A1 |
Provided is a resin which has a low linear thermal expansion coefficient and a low absorbance. This resin is characterized by comprising at least one structure that is selected from among structures represented by general formula (1) or ...
|
|
WO/2016/117663A1 |
The invention provides a precipitation accelerator that is an organic compound having one or more straight-chain aliphatic hydrocarbon groups having 10 or more carbon atoms, the total number of carbon atoms in these aliphatic hydrocarbon...
|
|
WO/2016/110805A1 |
The present invention relates to a process for the preparation of ospemifene and pharmaceutically acceptable salts thereof which comprises the step of recycling the undesired E-4-(4-hydroxy-1,2-diphenylbut-1-enyl)phenol to generate an is...
|
|
WO/2016/102472A1 |
The present invention relates to the cosmetic use, in a composition containing a physiologically acceptable medium, of at least one compound of formula (1): in which: - R1 means a hydrogen atom, a linear or branched C1-C6 alkyl radical; ...
|
|
WO/2016/101104A1 |
Disclosed is a method for preparing a double end capped glycol ether, the method comprising: introducing into a reactor a raw material comprising a glycol monoether and a monohydric alcohol ether, and enabling the raw material to contact...
|
|
WO/2016/104518A1 |
The purpose of the present invention is to provide a method in which a fluorine-containing olefin that is readily industrially available is used to simply and efficiently produce a separate fluorine-containing olefin by olefin metathesis...
|
|
WO/2016/104523A1 |
The purpose of the present invention is to provide a method in which a readily industrially available olefin containing chlorine and fluorine is used to simply and efficiently produce a separate olefin containing chlorine and fluorine by...
|
|
WO/2016/105907A1 |
Described herein is method of making a halogenated partially fluorinated compound, comprising: (a) providing a compound having the following structure of formula (I): Rf-CF=CXY wherein X and Y are independently selected from F and C1; wh...
|
|
WO/2016/102475A1 |
The present invention relates to the cosmetic use, in a composition containing a physiologically acceptable medium, of at least one compound of formula (I) in which: - R3 means a hydrogen atom or a hydroxyl radical, - R1 and R2 mean, ind...
|
|
WO/2016/101335A1 |
A method for extracting an alcohol-soluble substance from bark of pinus sylvestris, the method comprising the following steps: (1) pulverizing bark of pinus sylvestris into particles having a size of 20-80 mesh, adding the same into n-he...
|
|
WO/2016/096905A1 |
This invention concerns the first mild and efficient synthesis of primary amines and amides from aldehydes or ketones using a heterogeneous metal catalystand amine donor. The initial heterogeneous metal- catalyzed reaction between the ca...
|
|
WO/2016/100542A1 |
Disclosed are compounds, for example, compounds of formula (I), (Formula (I) wherein R, R0, R1-R8, n, X, Y, Y', and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a...
|
|
WO/2016/092900A1 |
A method for producing a fluoropolyether that contains an acid fluoride and has a low molecular weight by decomposing a triflate or trifluoroacetate of a fluoropolyether having a hydroxyl group in the presence of a Lewis acid.
|
|
WO/2016/093188A1 |
Provided is a non-ionic surfactant exhibiting little foaming, high alkaline stability, and a strong cleaning power. This non-ionic surfactant is characterized by having a structure represented by general formula (1). In general formula (...
|
|
WO/2016/092076A1 |
The present invention relates to novel compounds of formula (I) to cosmetic compositions comprising same, and also to the use thereof for preventing and/or cosmetically treating the signs of aging of the skin.
|
|
WO/2016/093175A1 |
According to the present invention, various tri(hetero)arylacetonitrile compounds are synthesized by reacting, in the presence of a palladium catalyst, a di(hetero)arylacetonitrile compound represented by the formula: CHAr1Ar2CN (Ar1 and...
|
|
WO/2016/092074A1 |
The present invention relates to novel compounds of formula (I) to compositions comprising same, and also to the use thereof for preventing and/or cosmetically treating the signs of aging of the skin.
|
|
WO/2016/089617A1 |
Described herein are three methods for making halogenated fluorinated ether-containing compounds using a fluorinated olefin or hexafluoropropylene oxide.
|
|
WO/2016/088620A1 |
Disclosed is a method for producing a compound represented by the general formula (I') [in the formula, the symbols have the same meanings as those described in the description]. The method entails reacting a compound represented by gene...
|
|
WO/2016/084565A1 |
Provided is a method for manufacturing a compound having an excellent reaction rate (high reaction rate). The method for manufacturing a compound includes a step for supplying, into a reaction vessel: compound (1) which has at least one ...
|
|
WO/2016/084024A1 |
The present invention is directed to oxidized lipids and pharmaceutical compositions comprising the same. The present invention is also directed to methods of making an oxidized lipid of the invention and to methods of treating or preven...
|
|
WO/2016/084781A1 |
The purpose of the present invention is to provide a fluoropolyether compound which has exceptional heat resistance and with which it is possible to maintain the lubricity of a magnetic disk surface without evaporating at high temperatur...
|
|
WO/2016/085825A1 |
Described herein, inter alia, are compositions and methods for treating or preventing hyperproliferative disorders, including cancer.
|
|
WO/2016/078603A1 |
The synthesis of fluorescent molecules with aggregation-induced emission (AIE) characteristics and application as fluorescent probes for cellular imaging, killing, and antibiotic screening, wherein the cells are bacteria or mammalian cel...
|
|
WO/2016/077968A1 |
A method for preparing methyl formate and coproducing dimethyl ether. A raw material containing formaldehyde and methanol is introduced into a first reaction area to come into contact with catalyst A and be separated therefrom, constitue...
|
|
WO/2016/077967A1 |
The present application relates to a method for preparing methyl formate. A raw material containing formaldehyde, methanol and/or dimethyl ether is introduced into a first reaction area to come into contact with catalyst A and be separat...
|
|
WO/2016/078389A1 |
The present invention relates to a liquid crystal compound having a structure represented by formula I, wherein R is selected from H, and unsubstituted alkyl or alkoxy, or the alkyl or alkoxy in which one or more Hs are substituted by ha...
|
|
WO/2016/076192A1 |
Provided is a mixture containing a compound A having at least one -CF2O- in the structure thereof, and free of -COO- in the structure thereof, and a compound B having a structure with at least one -CF2O- in compound A being substituted w...
|
|
WO/2016/075257A1 |
The regio-selective functionalization of a dialkyl benzene compound formula (I), wherein the ratio of the compound functionalized at position (a) to the compound functionalized at the position (b) is at least 70:30, more particularly at ...
|
|
WO/2016/074699A1 |
A fragrance precursor represented by the formula 1 wherein X and Y together represent a double bond to a carbon atom bearing R1 and R2, with R1 = H, methyl, acetyl or C1 -C3 alkoxycarbonyl (e.g. ethoxycarbonyl); and R2 = phenyl optionall...
|
|
WO/2016/073750A1 |
The present application provides, among other things, compounds and methods for metathesis reactions. In some embodiments, the present disclosure provides methods for preparing alkenyl halide with regioselectivity and/or stereoselectivit...
|
|
WO/2016/070708A1 |
Disclosed is a fluorinated liquid crystal containing a difluoromethoxy (CF2O) bridge bond and a composition thereof as well as the preparation method and use thereof. In the method of the present invention, difluoro dibromomethane is use...
|
|
WO/2016/071425A1 |
The invention discloses a method for preparation of fluoro, chloro and fluorochloro alkylated compounds by homogeneous Pd catalyzed fluoro, chloro and fluorochloro alkylation with fluoro, chloro and fluorochloroalkyl halides in the prese...
|
|
WO/2016/071723A1 |
The present invention relates to a process for the preparation of a 4,4'- bis(fluorobenzene) derivative, which is an intermediate compound in the synthesis of some drugs, for example in the synthesis of fluspirilene. The invention furthe...
|
|
WO/2016/068605A1 |
The present description relates to a fluorine-based compound for a brancher, polymer using same, a polymer electrolyte membrane using same, a fuel cell using same, and a redox flow battery comprising same.
|
|
WO/2016/066835A1 |
The present invention relates to a mild method of reducing a C-O bond to the corresponding C-H bond in a substrate, which could be a benzylic alcohol, allylic alcohol, ester or an ether bond beta to a hydroxyl group or alpha to a carbony...
|
|
WO/2016/063957A1 |
Provided are: a decalin derivative having a glycidyloxy group or an allyloxy group; and a method for producing the decalin derivative. A decalin derivative represented by formula (1) is produced by: a method comprising reacting a hydroxy...
|
|
WO/2016/059972A1 |
The purpose of the present invention is to provide a photovoltaic element having high photoelectric conversion efficiency as well as excellent processing properties/low environmental load. Specifically, the present invention is: an organ...
|
|
WO/2016/058080A1 |
Compounds having a structure of Formula I: or a pharmaceutically acceptable salt or stereoisomer thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9 and R10 are as defined herein, and wherein at least one of R1, R2, R3, R4 or R5 is F, ar...
|
|
WO/2016/058082A1 |
Compounds having a structure of Formula I: (I) or a pharmaceutically acceptable salt or stereoisomer thereof, wherein R1, R2, R3, R4, Z, X and n are as defined herein, and wherein the compound comprises at least one 18F moiety, are provi...
|
